Inhibition of autoimmune encephalomyelitis by a tetracycline

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases

Liblau, R., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,111

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006

MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES

González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia

Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958

Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis

Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T. P., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 935

Glutamate excitotoxicity in a model of multiple sclerosis

Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744

Matrix metalloproteinases and diseases of the CNS

Yong, V. W., Forsyth, P. A., Bell, R. B., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 635

Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology

Storch, M., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 566

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547

Minocycline Provides Neuroprotection Against N -Methyl- d -aspartate Neurotoxicity by Inhibiting Microglia

Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 539

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 532

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

Smith, T., Groom, A., Zhu, B., & Turski, L. (2000) · Nature Medicine · doi:10.1038/71548 · Cited by 467

Interleukin‐10 prevents experimental allergic encephalomyelitis in rats

Rott, O., Fleischer, B., & Cash, E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240629 · Cited by 367

The link between excitotoxic oligodendroglial death and demyelinating diseases

Matute, C., Alberdi, E. M., Domercq, M., Pérez‐Cerdá, F., Pérez‐Samartín, A., & Sánchez‐Gómez, M. V. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01746-x · Cited by 346

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement

Piddlesden, S. J. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90424-6 · Cited by 288

Progress in determining the causes and treatment of multiple sclerosis

Noseworthy, J. H. (1999) · Nature · doi:10.1038/399a040 · Cited by 275

Safety of long-term high-dose minocycline in the treatment of acne

Goulden, V., GLASS, D., & Cunliffe, W. J. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb06972.x · Cited by 218

Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis

Powers, J. M., & Moser, H. W. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00139.x · Cited by 208

Matrix metalloproteinases in inflammatory demyelination

Kieseier, B. C., Seifert‐Held, T., Giovannoni, G., & Hartung, H. (1999) · Neurology · doi:10.1212/wnl.53.1.20 · Cited by 167

Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.

Greenwald, R. A., Moak, S. A., Ramamurthy, N. S., & Golub, L. M. (1992) · PubMed · Cited by 164

Interleukin‐12 induces interferon‐γ‐dependent switching of IgG alloantibody subclass

Gracie, J. A., & Bradley, J. A. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260605 · Cited by 156

Indictment of the microglia as the villain in multiple sclerosis

Sriram, S., & Rodriguez, M. (1997) · Neurology · doi:10.1212/wnl.48.2.464 · Cited by 148

Myelin Oligodendrocyte Glycoprotein Induces Experimental Autoimmune Encephalomyelitis in the “Resistant” Brown Norway Rat: Disease Susceptibility Is Determined by MHC and MHC-Linked Effects on the B Cell Response

Stefferl, A., Brehm, U., Storch, M. K., Lambracht‐Washington, D., Bourquin, C., Wonigeit, K., Lassmann, H., & Linington, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.40 · Cited by 143

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement

Piddlesden, S. J., Lassmann, H., Zimprich, F., Morgan, B. P., & Linington, C. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)91046-f · Cited by 137

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors

Liedtke, W., Cannella, B., Mazzaccaro, R. J., Clements, J. M., Miller, K., Wucherpfenning, K. W., Gearing, A. J. H., & Raine, C. S. (1998) · Annals of Neurology · doi:10.1002/ana.410440110 · Cited by 128

Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells

Khoruts, A., Miller, S. D., & Jenkins, M. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5011 · Cited by 126

Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

Graesser, D., Mahooti, S., & Madri, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00275-7 · Cited by 88

Macrophage responses in inflammatory demyelinating neuropathies

Griffin, J. W., Stoll, G., Li, C. Y., Tyor, W. R., & Cornblath, D. R. (1990) · Annals of Neurology · doi:10.1002/ana.410270717 · Cited by 81

TGF-β induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia

Schlapbach, R., Spanaus, K., Malipiero, U., Lens, S. M. A., Tasinato, A., Tschopp, J., & Fontana, A. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12 · Cited by 74

Treatment of Destructive Arthritic Disorders with MMP Inhibitors

Greenwald, R. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24734.x · Cited by 72

Rattlesnake Hunting Behavior: Correlations between Plasticity of Predatory Performance and Neuroanatomy

Kardong, K. V., & Berkhoudt, H. (1998) · Brain Behavior and Evolution · doi:10.1159/000006579 · Cited by 65

MINOCYCLINE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Alarcón, G. S. (1998) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70022-3 · Cited by 17

Interleukin‐10 is an Unequivocal Th2 Parameter in the Rat, whereas Interleukin‐4 is Not *

Vandebriel, R. J., Meredith, C., Scott, M. P., van Dijk, M., & Loveren, H. V. (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00804.x · Cited by 16

Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights substrates of disability

Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2

The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2

Eugster (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1521-4141(199807)28:07 · Cited by 2

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2

Minocycline: Far beyond an Antibiotic

Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935

The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology

Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821

Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases

Hu, J., den Steen, P. E. V., Sang, Q. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 806

Pathophysiology and pharmacologic treatment of acute spinal cord injury*1

Kwon, B. K. (2004) · The Spine Journal · doi:10.1016/j.spinee.2003.07.007 · Cited by 705

Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation

Ledeboer, A., Sloane, E. M., Milligan, E. D., Frank, M. G., Mahony, J. H., Maier, S. F., & Watkins, L. R. (2005) · Pain · doi:10.1016/j.pain.2005.02.009 · Cited by 677

The prospects of minocycline in multiple sclerosis.

Chen, X.-H., Ma, X.-M., Jiang, Y., Pi, R., Liu, Y.-Y., & Ma, L.-L. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.006 · Cited by 75

Potential antibiotic treatment for multiple sclerosis?

Love, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07248-3 · Cited by 6

Minocycline ameliorates CNS autoimmunity through restraint of CD4+CD11bc+ cells

Milosavljević, Z., Lazarević, M. N., Stegnjaić, G., Nikolovski, N., Mirković, K., Lodygin, D., Flügel, A., Miljković, Đ., Stanisavljević, S., & Jevtić, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1823730

Targeting leukocyte MMPs and transmigration

Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C. A., & Yong, V. W. (2002) · Brain · doi:10.1093/brain/awf133 · Cited by 427

Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord

Nikodémová, M., Lee, J., Fábry, Z., & Duncan, I. D. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.009 · Cited by 36